// App-Quantinova.ai

349 : Heterogeneity of circulating tumor cells isolated from bladder cancer patients using ApoStream and biomarkers of epithelial-mesenchymal transition.

Researchers

Presenter

  • Colin P. N. Dinney

Principal Investigators

  • Vladislava O. Melnikova

  • Shanna M. Pretzsch

  • Miguel Garza

  • Weiguo Wu

  • Darren W. Davis

  • Kenna Lynn Anderes

Medical Centers

  • ApoCell, Inc., Houston, TX

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final